Skip to main content

Table 4 Univariate Analysis of Potential Factors Associated with Increased Time to Drain Removal Following Inguino-femoral Lymph Node Dissection (ILND)a

From: Fibrin sealant does not decrease seroma output or time to drain removal following inguino-femoral lymph node dissection in melanoma patients: A randomized controlled trial (NCT00506311)

Variable

Regression Coefficient

Standard error

P-value

Median BMI

0.01

0.01

0.37

Comorbidity

   

   Tobacco use

-0.03

0.24

0.90

   Diabetes

0.04

0.20

0.86

Prior systemic therapy

-0.05

0.18

0.80

Treatment group (fibrin sealant versus control)

3.31

0.11

0.88

Type of surgery (superficial +/- deep pelvic ILND)

-0.01

0.16

0.95

Total no. of lymph nodes removed (< 17 versus ≥ 17)

-0.15

0.14

0.32

No. of positive lymph nodes (< 2 versus ≥ 2)

0.01

0.15

0.95

Wound infection

   

   Major

-0.02

0.20

0.94

   Major plus minor

0.01

0.15

0.95

  1. BMI, body mass index; ILND, inguino-femoral lymph node